Adaptive Parkinson Infusion Therapy via Multi-Parameter Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional infusion therapies for Parkinson's disease, such as levodopa and dopamine agonists, face challenges in maintaining consistent motor control due to fluctuations in dopamine levels, leading to motor OFF phases and dyskinesias, and existing adaptive Deep Brain Stimulation methods are invasive and rely solely on brain activity measurements.
Innovation Solution
A system that uses voice and facial analysis, tremor and movement analysis, and levodopa and monoamine metabolite levels in subcutaneous interstitial fluid to automatically adjust the drug infusion rate through a micro-dialysis pump and processing device, integrated with an electronic bracelet, camera, and recorder, to maintain optimal motor performance by continuously monitoring and adapting the infusion therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If continuous administration systems of levodopa or dopamine agonists are used, then motor OFF time is reduced, but dyskinesias are induced
Solution Approach 1:
The system continuously monitors motor status through multiple parameters (voice analysis, facial analysis, tremor and movement analysis, levodopa and monoamine metabolite levels) and uses this feedback to dynamically adjust the infusion rate, creating a closed-loop control system that adapts therapy to real-time patient needs
Solution Approach 2:
The infusion rate is made dynamic rather than fixed, allowing real-time adjustments based on detected motor phase transitions. The system transitions from static dosing to adaptive dosing that responds to changing dopamine levels and motor status throughout the day
2Adaptability or versatility
If adaptive DBS is used, then stimulation is calibrated to patient status, but the method is highly invasive and relies solely on brain activity measurements
Solution Approach 1:
The system uses subcutaneous interstitial fluid as an intermediary medium to indirectly measure levodopa and monoamine metabolite levels, avoiding direct brain tissue insertion while still obtaining reliable pharmacokinetic data for therapy adjustment
Solution Approach 2:
The system replaces the mechanical/electrical intrusion of brain electrodes with non-invasive or minimally invasive sensing methods, including acoustic analysis of voice, optical analysis of facial expressions, and biochemical analysis of interstitial fluid, to detect motor status
3Reliability
If conventional DBS is used, then motor symptoms are controlled, but stimulation is constantly delivered with fixed intensity not suited to fluctuating needs
Solution Approach 1:
The system transitions from fixed-intensity stimulation to dynamic intensity adjustment, where the infusion rate and stimulation parameters are continuously adapted based on real-time detection of motor phase transitions and dopamine levels
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively maintains continuous motor ON states by dynamically adjusting the infusion rate, minimizing motor OFF phases and dyskinesias, while being minimally invasive and using multi-parametric monitoring for personalized therapeutic management.
Implementation Method 1
a micro-dialysis pump, connected to an analyzer unit and a subcutaneous needle, designed to collect and analyze samples of interstitial fluid to determine the levels of levodopa and monoamine metabolites in said subcutaneous interstitial fluid
Implementation Method 2
an electronic bracelet, equipped with an accelerometer, a magnetometer and a triaxial gyroscope, used to collect continuous data on tremor and movement
Implementation Method 3
a camera to capture facial expressions, to be activated at the request of the patient
Implementation Method 4
a recorder, to record the patient's voice, to be activated at the request of the patient
Data Source
AI summary
A method and a system are described, for managing an infusion therapy in the Parkinson's disease, through the analysis of the motion status of patients, wherein the motion status can be in one of the following phases: OFF phase, wherein Parkinson's symptoms, such as rigidity, tremor and bradykinesia, emerge; ON phase wherein the symptoms markedly improve; DIS phase wherein involuntary movements emerge, called dyskinesias; as detectors of the symptoms the following parameters are used: voice analysis; face analysis; tremor analysis; movement analysis; levodopa and metabolite levels of monoamines in the sub-cutaneous interstitial liquid of the patients; an algorithm being provided, which automatically modifies the infusion rate of a drug during the day, the infusion rate being computed by using the parameters as detectors.